Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Danaher Corp DHR.39


Primary Symbol: DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.


NYSE:DHR - Post by User

Bullboard Posts
Post by bc4uon Jan 29, 2013 8:32am
555 Views
Post# 20903977

Danaher Reports Record Fourth Quarter 2012 Results

Danaher Reports Record Fourth Quarter 2012 Results

Danaher Reports Record Fourth Quarter 2012 Results

WASHINGTON, Jan. 29, 2013 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2012. All financial metrics in this release reflect only the Company's continuing operations unless otherwise noted.

Net earnings for the quarter ended December 31, 2012 were $630.4 million, or $0.89 per share on a diluted basis, a 12.5% increase over diluted net earnings per share of $0.79 for the fourth quarter 2011. Included in the fourth quarter 2012 results is a $0.02 per share benefit from a mark-to-market gain from the change in value of a currency swap agreement. Sales for the 2012 fourth quarter were $4.98 billion, 5.5% higher than the $4.72 billion reported for the 2011 fourth quarter. Core revenues increased 3.5% in the quarter compared to the fourth quarter of 2011.

Net earnings for the full year 2012 were $2.3 billion, or $3.23 per share on a diluted basis, compared with net earnings of $1.9 billion, or $2.77 per share on a diluted basis for the full year 2011. Revenues for the full year 2012 were $18.3 billion compared to $16.1 billion for the full year 2011, an increase of 13.5%. Core revenues increased 2.5% for the full year 2012 compared to the full year 2011.

The Company expects to close on the pending divestiture of its interest in Apex Tool Group within the next two weeks and as a result it is updating its full year 2013 non-GAAP adjusted diluted net earnings per share guidance range to $3.32 to $3.47 from a previous GAAP diluted net earnings per share range of $3.40 to $3.55. The Company anticipates that non-GAAP adjusted diluted net earnings per share for the quarter ending March 29, 2013 will be in the range of $0.72 to $0.77. The adjusted guidance excludes the anticipated gain on the disposition of Apex as well as any benefit related to the retroactive reinstatement of certain federal tax provisions contained in the American Tax Relief Act of 2012.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "We were pleased by the strong finish to 2012, which was broad-based across most of our businesses. The team's application of the Danaher Business System led to a solid year of earnings growth, year-over-year core margin expansion and outstanding cash flow performance including a record $3.0 billion of free cash flow generation. While cognizant of the current macroeconomic challenges, we will continue our focus on gaining market share and remaining active on the acquisition front in 2013."

Danaher will discuss its results during its investor conference call today starting at 8:00 a.m. EST

https://phx.corporate-ir.net/phoenix.zhtml?c=82105&p=RssLanding&cat=news&id=1778747

DHR Chart
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=dhr&time=6&startdate=1%2F4%2F1999&enddate=1%2F8%2F2012&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=&ma=4&maval=9+15+50&uf=7168&lf=1&lf2=4&lf3=2&type=4&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=0&y=0

Analyst Estimates
https://www.marketwatch.com/investing/stock/dhr/analystestimates

Bullboard Posts